pillbase.ru

BUPROPION HYDROCHLORIDE

Active substance: Bupropion

TABLET, EXTENDED RELEASE · BUPROPION HYDROCHLORIDE 150 mg/1

United StatesActive

Marketing holder: REMEDYREPACK INC.

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
EU 1
  • Mysimba
    bupropion hydrochloride, naltrexone hydrochloride
    EMEA/H/C/003687
    Orexigen Therapeutics Ireland Limited
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-273b-7bad-8eff-8a7560f1e9c0,01a1208c-2752-724b-8f94-0f16aa40c3a4,01a1208c-29db-7d45-b421-b9aa063fde8b,01a1208c-2cfe-72dd-9a88-34a9c272d0ab,01a1208c-328f-775e-9927-8c2eeaac0396;count=347 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
70518-2458
Registration status
Active
Dispensing
Prescription only
Route
ORAL
Sources
  • product · openFDA NDC · 70518-2458 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 70518-2458 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 70518-2458 · Verified 2026-10-09 · open in source